Search Results - "Breakefield, XO"

Refine Results
  1. 1

    Extracellular vesicles: biology and emerging therapeutic opportunities by EL Andaloussi, Samir, Mäger, Imre, Breakefield, Xandra O., Wood, Matthew J. A.

    Published in Nature reviews. Drug discovery (01-05-2013)
    “…Extracellular vesicles have emerged as important mediators of intercellular communication, and they are now implicated in numerous biological and pathological…”
    Get full text
    Journal Article
  2. 2

    Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo by Tannous, Bakhos A, Kim, Dong-Eog, Fernandez, Juliet L, Weissleder, Ralph, Breakefield, Xandra O

    Published in Molecular therapy (01-03-2005)
    “…Photoproteins have played a major role in advancing our understanding of biological processes. A broader array of biocompatible, nontoxic, and novel reporters…”
    Get full text
    Journal Article
  3. 3

    Viral vectors for gene delivery to the nervous system by Davidson, Beverly L, Breakefield, Xandra O

    Published in Nature reviews. Neuroscience (01-05-2003)
    “…Our ability to manipulate the genetic constitution of the nervous system has come of age with various technologies, including virus vectors that can…”
    Get full text
    Journal Article
  4. 4

    Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector by MCKEE, Trevor D, GRANDI, Paola, MOK, Wilson, ALEXANDRAKIS, George, INSIN, Numpon, ZIMMER, John P, BAWENDI, Moungi G, BOUCHER, Yves, BREAKEFIELD, Xandra O, JAIN, Rakesh K

    Published in Cancer research (Chicago, Ill.) (01-03-2006)
    “…Oncolytic viral therapy provides a promising approach to treat certain human malignancies. These vectors improve on replication-deficient vectors by increasing…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Molecular imaging of gene therapy for cancer by SHAH, K, JACOBS, A, BREAKEFIELD, X. O, WEISSLEDER, R

    Published in Gene therapy (01-08-2004)
    “…Gene therapy of cancer has been one of the most exciting and elusive areas of scientific and clinical research in the past decade. One of the most critical…”
    Get full text
    Journal Article
  7. 7

    TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation by McLean, Pamela J., Kawamata, Hibiki, Shariff, Saadat, Hewett, Jeffrey, Sharma, Nutan, Ueda, Kenji, Breakefield, Xandra O., Hyman, Bradley T.

    Published in Journal of neurochemistry (01-11-2002)
    “…TorsinA, a protein with homology to yeast heat shock protein104, has previously been demonstrated to colocalize with α‐synuclein in Lewy bodies, the…”
    Get full text
    Journal Article
  8. 8

    Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression by Shah, Khalid, Bureau, Emilie, Kim, Dong-Eog, Yang, Katherine, Tang, Yi, Weissleder, Ralph, Breakefield, Xandra O.

    Published in Annals of neurology (01-01-2005)
    “…Despite many refinements in current therapeutic strategies, the overall prognosis for a patient with glioblastoma is dismal. Neural precursor cells (NPCs) are…”
    Get full text
    Journal Article
  9. 9

    TorsinA in the Nuclear Envelope by Naismith, Teresa V., Heuser, John E., Breakefield, Xandra O., Hanson, Phyllis I., De Camilli, Pietro V.

    “…Early-onset torsion dystonia, a CNS-based movement disorder, is usually associated with a single amino acid deletion (ΔE302/303) in the protein torsinA…”
    Get full text
    Journal Article
  10. 10
  11. 11

    FGF-2 Regulation of Neurogenesis in Adult Hippocampus after Brain Injury by Yoshimura, Shinichi, Takagi, Yasushi, Harada, Jun, Teramoto, Tetsuyuki, Thomas, Sunu S., Waeber, Christian, Bakowska, Joanna C., Breakefield, Xandra O., Moskowitz, Michael A.

    “…Fibroblast growth factor-2 (FGF-2) promotes proliferation of neuroprogenitor cells in culture and is up-regulated within brain after injury. Using mice…”
    Get full text
    Journal Article
  12. 12

    In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis by Shah, Khalid, Tung, Ching-Hsuan, Breakefield, Xandra O, Weissleder, Ralph

    Published in Molecular therapy (01-06-2005)
    “…Therapeutic proteins with specific effector functions play an increasingly important role in drug therapy. For example, tumor necrosis factor-related…”
    Get full text
    Journal Article
  13. 13

    Impaired Motor Learning in Mice Expressing TorsinA with the DYT1 Dystonia Mutation by Sharma, Nutan, Baxter, Mark G, Petravicz, Jeremy, Bragg, D. Cristopher, Schienda, Alonna, Standaert, David G, Breakefield, Xandra O

    Published in The Journal of neuroscience (01-06-2005)
    “…Primary early-onset generalized dystonia is an autosomal dominant disorder caused by a deletion (DeltaGAG) in the DYT1 gene encoding torsinA. The gene defect…”
    Get full text
    Journal Article
  14. 14

    Metabolic biotinylation of cell surface receptors for in vivo imaging by Weissleder, Ralph, Tannous, Bakhos A, Grimm, Jan, Perry, Katherine F, Chen, John W, Breakefield, Xandra O

    Published in Nature methods (01-05-2006)
    “…We have developed a versatile, potent technique for imaging cells in culture and in vivo by expressing a metabolically biotinylated cell-surface receptor and…”
    Get full text
    Journal Article
  15. 15

    FGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice by Yoshimura, S, Teramoto, T, Whalen, MJ, Irizarry, M C, Takagi, Y, Qiu, J, Harada, J, Waeber, C, Breakefield, X O, Moskowitz, MA

    Published in The Journal of clinical investigation (01-10-2003)
    “…We studied the role of FGF-2 on regulation of neurogenesis and cell loss in the granule cell layer (GCL) of the hippocampal dentate gyrus after experimental…”
    Get full text
    Journal Article
  16. 16

    Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics by Hewett, Jeffrey W., Zeng, Juan, Niland, Brian P., Bragg, D. Cristopher, Breakefield, Xandra O.

    Published in Neurobiology of disease (01-04-2006)
    “…Early onset torsion dystonia is a movement disorder inherited as an autosomal dominant syndrome with reduced penetrance. Symptoms appear to result from altered…”
    Get full text
    Journal Article
  17. 17

    Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier by Kock, Norman, Naismith, Teresa V., Boston, Heather E., Ozelius, Laurie J., Corey, David P., Breakefield, Xandra O., Hanson, Phyllis I.

    Published in Human molecular genetics (15-04-2006)
    “…Four naturally occurring sequence variations have been found in the coding region of the DYT1 gene encoding torsinA. One of these, a 3 bp (ΔGAG) deletion,…”
    Get full text
    Journal Article
  18. 18

    TorsinA: Movement at Many Levels by Breakefield, Xandra O., Kamm, Christoph, Hanson, Phyllis I.

    Published in Neuron (19-07-2001)
    “…TorsinA is the causative protein in the human neurologic disease early onset torsin dystonia, a movement disorder involving dysfunction in the basal ganglia…”
    Get full text
    Book Review Journal Article
  19. 19

    Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin by Brown, Alice B, Yang, Wendy, Schmidt, Nils O, Carroll, Rona, Leishear, Kim K, Rainov, Nikolai G, Black, Peter M, Breakefield, Xandra O, Aboody, Karen S

    Published in Human gene therapy (10-12-2003)
    “…The remarkable migratory and tumor-tropic capacities of neural stem cells (NSCs and/or neuroprogenitor cells) represent a potentially powerful approach to the…”
    Get more information
    Journal Article
  20. 20